Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.07 billion. The enterprise value is $1.34 billion.
| Market Cap | 1.07B |
| Enterprise Value | 1.34B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 62.44 million shares outstanding. The number of shares has decreased by -5.85% in one year.
| Shares Outstanding | 62.44M |
| Shares Change (YoY) | -5.85% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 0.94% |
| Owned by Institutions (%) | 120.52% |
| Float | 50.23M |
Valuation Ratios
The trailing PE ratio is 7.78 and the forward PE ratio is 25.93. Innoviva's PEG ratio is 0.24.
| PE Ratio | 7.78 |
| Forward PE | 25.93 |
| PS Ratio | 3.45 |
| Forward PS | 4.66 |
| PB Ratio | 1.53 |
| P/FCF Ratio | 7.06 |
| PEG Ratio | 0.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.22, with an EV/FCF ratio of 8.82.
| EV / Earnings | 7.40 |
| EV / Sales | 4.31 |
| EV / EBITDA | 5.22 |
| EV / EBIT | 6.14 |
| EV / FCF | 8.82 |
Financial Position
The company has a current ratio of 10.42, with a Debt / Equity ratio of 0.63.
| Current Ratio | 10.42 |
| Quick Ratio | 8.51 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 1.74 |
| Debt / FCF | 2.94 |
| Interest Coverage | 10.62 |
Financial Efficiency
Return on equity (ROE) is 28.30% and return on invested capital (ROIC) is 8.35%.
| Return on Equity (ROE) | 28.30% |
| Return on Assets (ROA) | 15.10% |
| Return on Capital (ROIC) | 8.35% |
| Revenue Per Employee | $2.78M |
| Profits Per Employee | $1.62M |
| Employee Count | 112 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 0.99 |
Taxes
In the past 12 months, Innoviva has paid $16.69 million in taxes.
| Income Tax | 16.69M |
| Effective Tax Rate | 8.43% |
Stock Price Statistics
The stock price has increased by +34.61% in the last 52 weeks. The beta is 0.58, so Innoviva's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +34.61% |
| 50-Day Moving Average | 16.17 |
| 200-Day Moving Average | 15.19 |
| Relative Strength Index (RSI) | 66.43 |
| Average Volume (20 Days) | 564,819 |
Short Selling Information
The latest short interest is 11.27 million, so 18.05% of the outstanding shares have been sold short.
| Short Interest | 11.27M |
| Short Previous Month | 12.28M |
| Short % of Shares Out | 18.05% |
| Short % of Float | 22.45% |
| Short Ratio (days to cover) | 20.99 |
Income Statement
In the last 12 months, Innoviva had revenue of $311.59 million and earned $181.39 million in profits. Earnings per share was $2.21.
| Revenue | 311.59M |
| Gross Profit | 268.33M |
| Operating Income | 104.94M |
| Pretax Income | 198.08M |
| Net Income | 181.39M |
| EBITDA | 257.03M |
| EBIT | 218.66M |
| Earnings Per Share (EPS) | $2.21 |
Balance Sheet
The company has $178.36 million in cash and $446.76 million in debt, giving a net cash position of -$268.40 million or -$4.30 per share.
| Cash & Cash Equivalents | 178.36M |
| Total Debt | 446.76M |
| Net Cash | -268.40M |
| Net Cash Per Share | -$4.30 |
| Equity (Book Value) | 703.68M |
| Book Value Per Share | 11.27 |
| Working Capital | 281.46M |
Cash Flow
In the last 12 months, operating cash flow was $152.43 million and capital expenditures -$280,000, giving a free cash flow of $152.15 million.
| Operating Cash Flow | 152.43M |
| Capital Expenditures | -280,000 |
| Free Cash Flow | 152.15M |
| FCF Per Share | $2.41 |
Margins
Gross margin is 86.12%, with operating and profit margins of 33.68% and 58.21%.
| Gross Margin | 86.12% |
| Operating Margin | 33.68% |
| Pretax Margin | 63.57% |
| Profit Margin | 58.21% |
| EBITDA Margin | 82.49% |
| EBIT Margin | 70.18% |
| FCF Margin | 48.83% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.85% |
| Shareholder Yield | 5.85% |
| Earnings Yield | 16.90% |
| FCF Yield | 14.17% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 8.17% |
| EPS Growth Forecast (5Y) | -3.13% |
Stock Splits
The last stock split was on June 3, 2014. It was a forward split with a ratio of 1241:1000.
| Last Split Date | Jun 3, 2014 |
| Split Type | Forward |
| Split Ratio | 1241:1000 |
Scores
Innoviva has an Altman Z-Score of 2.24 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 5 |